Advancements in MELD Score and Its Impact on Hepatology
Seminars in Liver Disease · 01.06.2025 · 45 (02) · 236-251
DOI: 10.1055/a-2464-9543 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.06.2025. Verfasst von David Hudson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University and London Health Sciences Centre, London, Onta…. Hauptthemen laut MEDLINE: Liver Transplantation, End Stage Liver Disease, Patient Selection, Gastroenterology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
There continues to be an ongoing need for fair and equitable organ allocation. The Model for End-Stage Liver Disease (MELD) score has evolved as a calculated framework to evaluate and allocate patients for liver transplantation objectively. The original MELD score has undergone multiple modifications as it is continuously scrutinized for its accuracy in objectively representing the clinical context of patients with liver disease. Several refinements and iterations of the score have been developed, including the widely accepted MELD-Na score. In addition, the most recent updated iteration, MELD 3.0, has been created. The MELD 3.0 calculator incorporates new variables such as patient sex and serum albumin levels and assigns new weights for serum sodium, bilirubin, international normalized ratio, and creatinine levels. It is anticipated that the use of MELD 3.0 scores will reduce overall waitlist mortality and enhance access for female liver transplant candidates. However, despite the emergence of the MELD score as one of the most objective measures for fair organ allocation, various countries and healthcare systems employ alternative methods for stratification and organ allocation. This review article will highlight the origins of the MELD score, its iterations, the current MELD 3.0, and future directions for managing liver transplantation organ allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada.
- Obesity and Digestive Diseases Unit, Medica Sur Hospital, Mexico City, Mexico.
- Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Division of Gastroenterology and Hepatology, MASLD Research Center, University of California San Diego, San Diego, California.
ORCID-Profile: Francisco Javier Valentin Cortez, Ivonne Hurtado Díaz de León, Luis Antonio Diaz, Juan Pablo Arab
Zitieren
APA
Hudson, D., Valentin Cortez, F. J., León, I. H. D., Malhi, G., Rivas, A., Afzaal, T., Rad, M. R., Diaz, L. A., Khan, M. Q., & Arab, J. P. (2025). Advancements in MELD Score and Its Impact on Hepatology. Seminars in Liver Disease, 45(02), 236-251. https://doi.org/10.1055/a-2464-9543
Vancouver
Hudson D, Valentin Cortez FJ, León IHD, Malhi G, Rivas A, Afzaal T, et al. Advancements in MELD Score and Its Impact on Hepatology. Seminars in Liver Disease. 2025;45(02):236-251. doi:10.1055/a-2464-9543
BibTeX
@article{Hudson2025,
author = {Hudson, David and Valentin Cortez, Francisco Javier and León, Ivonne Hurtado Díaz de and Malhi, Gurpreet and Rivas, Angelica and Afzaal, Tamoor and Rad, Mahsa Rahmany and Diaz, Luis Antonio and Khan, Mohammad Qasim and Arab, Juan Pablo},
title = {Advancements in MELD Score and Its Impact on Hepatology},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {02},
pages = {236--251},
doi = {10.1055/a-2464-9543}
}
EUVIMED